Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment (TEAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04369430
Recruitment Status : Completed
First Posted : April 30, 2020
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
Alkahest, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 8, 2021
Actual Study Completion Date : April 8, 2021